{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:08:23Z","timestamp":1782169703713,"version":"3.54.5"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A vaccine for coccidioidomycosis is likely to undergo trials in the near future. In this paper, we raise 4 questions that should be answered before its use and offer our solutions to these questions. These include defining the goals of vaccination, determining who should be vaccinated, how to measure vaccine immunity and protection, and how to address vaccine hesitancy and denial.<\/jats:p>","DOI":"10.1093\/ofid\/ofae095","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T16:33:25Z","timestamp":1708360405000},"source":"Crossref","is-referenced-by-count":4,"title":["Challenges to Implementing a Vaccine for Coccidioidomycosis"],"prefix":"10.1093","volume":"11","author":[{"given":"Bridget M","family":"Barker","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Northern Arizona University , Flagstaff, Arizona , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8518-5750","authenticated-orcid":false,"suffix":"III","given":"George R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, University of California at Davis , Davis, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-4396","authenticated-orcid":false,"given":"Neil M","family":"Ampel","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Immunobiology, University of Arizona , Tucson, Arizona , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"2024061711524892400_ofae095-B1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/scientificamerican0621-26","article-title":"Deadly kingdom","volume":"324","author":"McKenna","year":"2021","journal-title":"Sci Am"},{"key":"2024061711524892400_ofae095-B2","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2021.10.029","article-title":"Deltacps1 vaccine protects dogs against experimentally induced coccidioidomycosis","volume":"39","author":"Shubitz","year":"2021","journal-title":"Vaccine"},{"key":"2024061711524892400_ofae095-B3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/vaccines12010067","article-title":"A recombinant multivalent vaccine (rCpa1) induces protection for C57BL\/6 and HLA transgenic mice against pulmonary infection with both species of Coccidioides","volume":"12","author":"Campuzano","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2024061711524892400_ofae095-B4","doi-asserted-by":"crossref","DOI":"10.17226\/26928","volume-title":"Impact and control of valley fever: proceedings of a workshop in brief","author":"Wouters","year":"2023"},{"key":"2024061711524892400_ofae095-B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1196\/annals.1406.031","article-title":"Coccidioides niches and habitat parameters in the southwestern United States: a matter of scale","volume":"1111","author":"Fisher","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"2024061711524892400_ofae095-B6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/mmy\/myu004","article-title":"Demonstration of Coccidioides immitis and Coccidioides posadasii DNA in soil samples collected from Dinosaur National Monument, Utah","volume":"52","author":"Johnson","year":"2014","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciu681","article-title":"Valley fever: finding new places for an old disease: coccidioides immitis found in Washington State soil associated with recent human infection","volume":"60","author":"Litvintseva","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024061711524892400_ofae095-B8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/mmy\/myw022","article-title":"Molecular detection of airborne Coccidioides in Tucson, Arizona","volume":"54","author":"Chow","year":"2016","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/mmy\/myz093","article-title":"The detection of Coccidioides from ambient air in Phoenix, Arizona: evidence of uneven distribution and seasonality","volume":"58","author":"Gade","year":"2020","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/jama.1964.03070240056021","article-title":"Epidemiology of coccidioidomycosis. A contemporary military experience","volume":"190","author":"Drips","year":"1964","journal-title":"JAMA"},{"key":"2024061711524892400_ofae095-B11","first-page":"100","article-title":"Coccidioidomycosis at a university health service","volume":"131","author":"Kerrick","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2024061711524892400_ofae095-B12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2105\/AJPH.75.8.863","article-title":"Estimates of C. immitis infection by skin test reactivity in an endemic community","volume":"75","author":"Dodge","year":"1985","journal-title":"Am J Public Health"},{"key":"2024061711524892400_ofae095-B13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/313724","article-title":"Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years","volume":"30","author":"Larwood","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2024061711524892400_ofae095-B14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1164\/ajrccm\/148.3.656","article-title":"Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group","volume":"148","author":"Pappagianis","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2024061711524892400_ofae095-B15","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/mmy\/myy039","article-title":"The endozoan, small-mammal reservoir hypothesis and the life cycle of Coccidioides species","volume":"57","author":"Taylor","year":"2019","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B16","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2105\/AJPH.36.12.1394","article-title":"Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases","volume":"36","author":"Smith","year":"1946","journal-title":"Am J Public Health Nations Health"},{"key":"2024061711524892400_ofae095-B17","doi-asserted-by":"crossref","first-page":"myac054","DOI":"10.1093\/mmy\/myac054","article-title":"Natural history of pulmonary coccidioidomycosis: further examination of the VA-Armed Forces Database","volume":"60","author":"Shemuel","year":"2022","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B18","doi-asserted-by":"crossref","first-page":"e3814","DOI":"10.1093\/cid\/ciaa1154","article-title":"Natural history of disseminated coccidioidomycosis: examination of the VA-Armed Forces Database","volume":"73","author":"Bays","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024061711524892400_ofae095-B19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3201\/eid0203.960305","article-title":"Coccidioidomycosis: a reemerging infectious disease","volume":"2","author":"Kirkland","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"2024061711524892400_ofae095-B20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/br.31.1.25-34.1967","article-title":"Epidemiological aspects of respiratory mycotic infections","volume":"31","author":"Pappagianis","year":"1967","journal-title":"Bacteriol Rev"},{"key":"2024061711524892400_ofae095-B21","first-page":"717","article-title":"Arrested pulmonary coccidioidomycosis granuloma","volume":"27","author":"Cox","year":"1939","journal-title":"Arch Path"},{"key":"2024061711524892400_ofae095-B22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(93)90054-S","article-title":"Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area","volume":"94","author":"Ampel","year":"1993","journal-title":"Am J Med"},{"key":"2024061711524892400_ofae095-B23","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/323463","article-title":"Coccidioidomycosis in solid organ transplantation","volume":"33","author":"Blair","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2024061711524892400_ofae095-B24","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/art.20454","article-title":"Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists","volume":"50","author":"Bergstrom","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2024061711524892400_ofae095-B25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/tropicalmed6040207","article-title":"Pandora's box: disseminated coccidioidomycosis associated with self-medication with an unregulated potent corticosteroid acquired in Mexico","volume":"6","author":"Coba","year":"2021","journal-title":"Trop Med Infect Dis"},{"key":"2024061711524892400_ofae095-B26","first-page":"959","article-title":"Ethnic background and the clinical course of coccidioidomycosis","volume":"120","author":"Pappagianis","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"2024061711524892400_ofae095-B27","author":"Spendlove"},{"key":"2024061711524892400_ofae095-B28","doi-asserted-by":"crossref","first-page":"ofab543","DOI":"10.1093\/ofid\/ofab543","article-title":"Sex differences in susceptibility to coccidioidomycosis","volume":"9","author":"McHardy","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024061711524892400_ofae095-B29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/cid\/cir410","article-title":"Coccidioidomycosis during pregnancy: a review and recommendations for management","volume":"53","author":"Bercovitch","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024061711524892400_ofae095-B30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3201\/eid2509.190023","article-title":"Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA","volume":"25","author":"Donovan","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2024061711524892400_ofae095-B31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3201\/eid0705.010505","article-title":"Cost-effectiveness of a potential vaccine for Coccidioides immitis","volume":"7","author":"Barnato","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"2024061711524892400_ofae095-B32","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1016\/S2214-109X(18)30346-2","article-title":"Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study","volume":"6","author":"Gouglas","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2024061711524892400_ofae095-B33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/jof2040034","article-title":"The quest for a vaccine against coccidioidomycosis: a neglected disease of the Americas","volume":"2","author":"Kirkland","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"2024061711524892400_ofae095-B34","first-page":"903","article-title":"FDA public workshop summary-coccidioidomycosis (valley fever): considerations for development of antifungal drugs","volume":"73","author":"O'Shaughnessy","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024061711524892400_ofae095-B35","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/jof8080838","article-title":"Vaccines to prevent coccidioidomycosis: a gene-deletion mutant of Coccidioides posadasii as a viable candidate for human trials","volume":"8","author":"Galgiani","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024061711524892400_ofae095-B36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/595687","article-title":"Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis","volume":"48","author":"Ampel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2024061711524892400_ofae095-B37","first-page":"330","article-title":"The use of coccidioidin","volume":"57","author":"Smith","year":"1948","journal-title":"Am Rev Tuberc"},{"key":"2024061711524892400_ofae095-B38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/CVI.00280-15","article-title":"Cytokine profiles from antigen-stimulated whole-blood samples among patients with pulmonary or nonmeningeal disseminated coccidioidomycosis","volume":"22","author":"Ampel","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"2024061711524892400_ofae095-B39","doi-asserted-by":"crossref","first-page":"ofaa623","DOI":"10.1093\/ofid\/ofaa623","article-title":"Clinical and economic burden of valley fever in Arizona: an incidence-based cost-of-illness analysis","volume":"8","author":"Grizzle","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2024061711524892400_ofae095-B40","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/mmy\/myy095","article-title":"Update on the epidemiology of coccidioidomycosis in the United States","volume":"57","author":"McCotter","year":"2019","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3201\/eid2408.171595","article-title":"Enhanced surveillance for coccidioidomycosis, 14 US States, 2016","volume":"24","author":"Benedict","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2024061711524892400_ofae095-B42","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1093\/mmy\/myy031","article-title":"Occupational coccidioidomycosis surveillance and recent outbreaks in California","volume":"57","author":"de Perio","year":"2019","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/tay027","article-title":"Travel-related risk factors for coccidioidomycosis","volume":"25","author":"Diaz","year":"2018","journal-title":"J Travel Med"},{"key":"2024061711524892400_ofae095-B44","first-page":"2","article-title":"Coccidioidomycosis, active component, U.S. armed forces, 2007\u20132017","volume":"25","author":"Williams","year":"2018","journal-title":"MSMR"},{"key":"2024061711524892400_ofae095-B45","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3201\/eid2607.200024","article-title":"Risk for coccidioidomycosis among Hispanic farm workers, California, USA, 2018","volume":"26","author":"McCurdy","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2024061711524892400_ofae095-B46","doi-asserted-by":"crossref","first-page":"931","DOI":"10.15585\/mmwr.mm6733a4","article-title":"Coccidioidomycosis outbreak among workers constructing a solar power farm\u2014Monterey County, California, 2016\u20132017","volume":"67","author":"Laws","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024061711524892400_ofae095-B47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajim.23218","article-title":"Coccidioidomycosis outbreak among inmate wildland firefighters: California, 2017","volume":"64","author":"Laws","year":"2021","journal-title":"Am J Ind Med"},{"key":"2024061711524892400_ofae095-B48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1078345817716451","article-title":"Increased coccidioidomycosis among inmates at a California prison: initial investigation in 2005 to 2006","volume":"23","author":"Lee","year":"2017","journal-title":"J Correct Health Care"},{"key":"2024061711524892400_ofae095-B49","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/jof9050554","article-title":"Genetic and other determinants for the severity of coccidioidomycosis: a Clinician's perspective","volume":"9","author":"Galgiani","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2024061711524892400_ofae095-B50","doi-asserted-by":"crossref","first-page":"790488","DOI":"10.3389\/fcimb.2021.790488","article-title":"Vaccine protection of mice with primary immunodeficiencies against disseminated coccidioidomycosis","volume":"11","author":"Powell","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2024061711524892400_ofae095-B51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-021-00294-8","article-title":"Vaccines for human fungal diseases: close but still a long way to go","volume":"6","author":"Oliveira","year":"2021","journal-title":"NPJ Vaccines"},{"key":"2024061711524892400_ofae095-B52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4049\/jimmunol.94.1.132","article-title":"Immunization of mice to Coccidioides immitis: dose, regimen and spherulation stage of killed spherule vaccines","volume":"94","author":"Levine","year":"1965","journal-title":"J Immunol"},{"key":"2024061711524892400_ofae095-B53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/oxfordjournals.aje.a113776","article-title":"Immunologic responsiveness and safety associated with the Coccidioides immitis spherule vaccine in volunteers of white, black, and Filipino ancestry","volume":"119","author":"Williams","year":"1984","journal-title":"Am J Epidemiol"},{"key":"2024061711524892400_ofae095-B54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/fgbi.2000.1243","article-title":"Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities","volume":"32","author":"Pappagianis","year":"2001","journal-title":"Fungal Genet Biol"},{"key":"2024061711524892400_ofae095-B55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1378\/chest.68.5.697","article-title":"Spherulin in clinical coccidioidomycosis","volume":"65","author":"Stevens","year":"1975","journal-title":"Chest"},{"key":"2024061711524892400_ofae095-B56","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1086\/516115","article-title":"Prediction of relapse after treatment of coccidioidomycosis","volume":"25","author":"Oldfield","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2024061711524892400_ofae095-B57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11046-012-9555-6","article-title":"A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis","volume":"174","author":"Johnson","year":"2012","journal-title":"Mycopathologia"},{"key":"2024061711524892400_ofae095-B58","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11046-019-00356-5","article-title":"An analysis of skin test responses to spherulin-based coccidioidin (Spherusol((R))) among a group of subjects with various forms of active coccidioidomycosis","volume":"184","author":"Ampel","year":"2019","journal-title":"Mycopathologia"},{"key":"2024061711524892400_ofae095-B59","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/mmy\/myz099","article-title":"Coccidioides (spherulin) skin testing in patients with pulmonary coccidioidomycosis in an endemic region","volume":"58","author":"Mafi","year":"2020","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.1958.02990030008003","article-title":"The solitary circumscribed pulmonary nodule; study of seven hundred five cases encountered roentgenologically in a period of three and one-half years","volume":"166","author":"Good","year":"1958","journal-title":"J Am Med Assoc"},{"key":"2024061711524892400_ofae095-B61","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1378\/chest.93.5.1003","article-title":"Clinical usefulness of lymphocyte transformation in patients with coccidioidomycosis","volume":"93","author":"Barbee","year":"1988","journal-title":"Chest"},{"key":"2024061711524892400_ofae095-B62","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/infdis\/165.4.710","article-title":"In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults","volume":"165","author":"Ampel","year":"1992","journal-title":"J Infect Dis"},{"key":"2024061711524892400_ofae095-B63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/mmy.38.2.127.132","article-title":"Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen","volume":"38","author":"Ampel","year":"2000","journal-title":"Med Mycol"},{"key":"2024061711524892400_ofae095-B64","first-page":"1039","article-title":"In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K","volume":"9","author":"Ampel","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"2024061711524892400_ofae095-B65","first-page":"700","article-title":"Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis","volume":"12","author":"Ampel","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2024061711524892400_ofae095-B66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/IAI.00953-09","article-title":"Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells","volume":"78","author":"Nesbit","year":"2010","journal-title":"Infect Immun"},{"key":"2024061711524892400_ofae095-B67","doi-asserted-by":"crossref","first-page":"e00065-18","DOI":"10.1128\/mSphere.00065-18","article-title":"Ex Vivo cytokine release, determined by a multiplex cytokine assay, in response to coccidioidal antigen stimulation of whole blood among subjects with recently diagnosed primary pulmonary coccidioidomycosis","volume":"3","author":"Ampel","year":"2018","journal-title":"mSphere"},{"key":"2024061711524892400_ofae095-B68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"2024061711524892400_ofae095-B69","doi-asserted-by":"crossref","first-page":"627932","DOI":"10.3389\/fimmu.2021.627932","article-title":"Cancer vaccines, adjuvants, and delivery systems","volume":"12","author":"Paston","year":"2021","journal-title":"Front Immunol"},{"key":"2024061711524892400_ofae095-B70","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/v15081760","article-title":"Vaccines\u2019 new era-RNA vaccine","volume":"15","author":"Zhou","year":"2023","journal-title":"Viruses"},{"key":"2024061711524892400_ofae095-B71","doi-asserted-by":"crossref","first-page":"e0280439","DOI":"10.1371\/journal.pone.0280439","article-title":"Understanding the barriers and facilitators of vaccine hesitancy towards the COVID-19 vaccine in healthcare workers and healthcare students worldwide: an Umbrella review","volume":"18","author":"McCready","year":"2023","journal-title":"PLoS One"},{"key":"2024061711524892400_ofae095-B72","first-page":"E47","article-title":"The old and the new: vaccine hesitancy in the era of the web 2.0. Challenges and opportunities","volume":"57","author":"Rosselli","year":"2016","journal-title":"J Prev Med Hyg"},{"key":"2024061711524892400_ofae095-B73","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3390\/vaccines10111777","article-title":"What contributes to COVID-19 vaccine hesitancy? A systematic review of the psychological factors associated with COVID-19 vaccine hesitancy","volume":"10","author":"Romate","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2024061711524892400_ofae095-B74","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/infdis\/jiz196","article-title":"Maize-produced Ag2 as a subunit vaccine for valley fever","volume":"220","author":"Hayden","year":"2019","journal-title":"J Infect Dis"},{"key":"2024061711524892400_ofae095-B75","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.4049\/jimmunol.1900793","article-title":"CARD9-Associated dectin-1 and dectin-2 are required for protective immunity of a multivalent vaccine against Coccidioides posadasii infection","volume":"204","author":"Campuzano","year":"2020","journal-title":"J Immunol"},{"key":"2024061711524892400_ofae095-B76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"2024061711524892400_ofae095-B77","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"2024061711524892400_ofae095-B78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1893062","article-title":"Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?","volume":"18","author":"Wiysonge","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2024061711524892400_ofae095-B79","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/vaccines11030630","article-title":"Learning from the past to improve the future-vaccine hesitancy determinants in the Italian population: a systematic review","volume":"11","author":"Ferrara","year":"2023","journal-title":"Vaccines (Basel)"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae095\/56707014\/ofae095.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae095\/58234225\/ofae095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae095\/58234225\/ofae095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:53:43Z","timestamp":1718625223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae095\/7610682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae095","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,2,19]]},"article-number":"ofae095"}}